The rockefeller university

Event Details

Type

Academic Symposia

Speaker(s)

9:00 a.m.: Marc Tessier-Lavigne, Ph.D., president, Carson Family Professor and head, Laboratory of Brain Development and Repair, The Rockefeller University, Welcome Remarks

9:10 a.m.: Andrew D. Luster, M.D., Ph.D., chief, division of rheumatology, allergy and immunology, Massachusetts General Hospital; Persis, Cyrus and Marlow B. Harrison Professor of Medicine, Harvard Medical School, What Do Chemokines Have to Do With Fc Receptors?

9:40 a.m.: Michel C. Nussenzweig, M.D., Ph.D., senior physician, The Rockefeller University Hospital, Zanvil A. Cohn and Ralph M. Steinman Professor and head, Laboratory of Molecular Immunology, The Rockefeller University; investigator, Howard Hughes Medical Institute, Antibody Responses in Humans and Mice

10:10 a.m.: Tomohiro Kurosaki, M.D., Ph.D., professor, laboratory of lymphocyte differentiation, WPI Immunology Frontier Research Center, Osaka University, Instructive Selection of Germinal Center B Cells into the Memory Compartment

10:40 a.m.: Alan A. Aderem, Ph.D., affiliate professor, department of medicine and department of immunology, University of Washington School of Medicine; president and director, Seattle Biomedical Research Institute, A Systems Approach to Dissecting Immunity

11:10 a.m.: Fubin Li, Ph.D., principal investigator, department of microbiology and immunology, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Immunology, Fc of Agonistic Antibodies

11:40 a.m.: Sir Marc Feldmann, Ph.D., M.B.B.S., professor and head, Kennedy Institute of Rheumatology, University of Oxford, Beyond Anti-TNF Therapy for Rheumatoid Arthritis: Can We Get Closer to a Cure?

1:30 p.m.: Toshiyuki Takai, Ph.D., professor, Laboratory of Experimental Immunology, Tohoku University School of Medicine, Regulatory Receptors Characterizing Peripheral B-Lineage Cells in SLE

2:00 p.m.: Mikael Karlsson, Ph.D., senior researcher and associate professor, department of microbiology, tumor and cell biology, Karolinska Institutet, Reprogramming Tumor-associated Macrophages by Antibody Targeting

2:30 p.m.: Roger M. Perlmutter, M.D., Ph.D., executive vice president and president of Merck Research Laboratories, Merck & Co., Inc., Immune-mediated Control of Malignant Disease

3:00 p.m.: Robert M. Anthony, Ph.D., principal investigator, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital; assistant professor of medicine, Harvard Medical School, Glycan Regulation of Immunoglobulins

3:45 p.m.: Tadatsugu Taniguchi, Ph.D., professor emeritus and project professor, department of molecular immunology, Institute of Industrial Science, The University of Tokyo, The Regulation of Immune Responses by Self-derived Molecules

4:15 p.m.: Falk Nimmerjahn, Ph.D., professor, department of biology, University of Erlangen-Nuremberg, Novel Humanized Mouse Models to Understand and Modulate Human IgG Activity

4:45 p.m.: Max D. Cooper, M.D., professor, department of pathology and laboratory medicine, professor, Emory Vaccine Center, investigator, Emory Center for AIDS Research, Emory University School of Medicine, Evolution of Adaptive Immunity

5:15 p.m.: Jeffrey V. Ravetch, M.D., Ph.D., Theresa and Eugene M. Lang Professor, Leonard Wagner Laboratory of Molecular Genetics and Immunology, The Rockefeller University, Closing Remarks

Event URL

https://giveandjoin.rockefeller.edu/ravetch

Open to

Public

Contact

Kathleen Gaffney

Phone

(212) 327-8967

Sponsor

Kathleen Gaffney
(212) 327-8967
kgaffney@rockefeller.edu